(A-1) SCIE veya SSCI kapsamındaki dergide yayımlanmış makale
1-) Tetik Vardarlı Aslı, Özgür Su, Göksel Tuncay, Korba Korcan, Karakuş Haydar Soydaner, Aşık Aycan, Pelit Levent, Gündüz Cumhur, 2023. Conversion of specific lncRNAs to biomarkers in exhaled breath condensate samples of patients with advanced stage non-small-cell lung cancer. Frontiers in genetics
2-) Yılmaz Uğur, Kamer Deniz, Aşık Aycan, Güler Kara Hale, Gündüz Cumhur, Kamer Emine Serra, 2023. The effect of the ATM inhibitor AZD0156 on the radiosensitivity of human breast cancer and lung fibroblast cells. Journal of Cancer Research and Therapeutics
3-) Güler Kara Hale, Özateş Neslihan Pınar, Aşık Aycan, Gündüz Cumhur, 2023. Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles. Medical Oncology
4-) Gasımlı Röya, Kayabaşı Çağla, Özmen Yelken Besra, Aşık Aycan, Söğütlü Fatma, Çelebi Çağlar, Yılmaz Süslüer Sunde, Kamer Emine Serra, Biray Avcı Çığır, Haydaroğlu Ayfer, Gündüz Cumhur, 2023. The effects of PKI-402 on breast tumor models' radiosensitivity via dual inhibition of PI3K/mTOR. International journal of radiation biology
5-) Kayabaşı Çağla, Caner Ayşe, Yılmaz Süslüer Sunde, Balcı Tuğçe, Özmen Yelken Besra, Aşık Aycan, Mutlu Zeynep, Çalışkan Cansu, Göker Bağca Bakiye, Biray Avcı Çığır, Şahin Fahri, Saydam Güray, Gündüz Cumhur, 2022. Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis. Medical Oncology
6-) Söğütlü Fatma, Kayabaşı Çağla, Özmen Yelken Besra, Aşık Aycan, Gasımlı Röya, Kıpçak Sezgi, Yılmaz Süslüer Sunde, Biray Avcı Çığır, Gündüz Cumhur, 2021. The Evaluation of Effect of Aurora Kinase Inhibitor CCT137690 in Melanoma and Melanoma Cancer Stem Cell. Anti-Cancer Agents in Medicinal Chemistry
7-) Kayabaşı Çağla, Özmen Yelken Besra, Aşık Aycan, Balcı Tuğçe, Söğütlü Fatma, Gasımlı Röya, Yılmaz Süslüer Sunde, Saydam Güray, Biray Avcı Çığır, Gündüz Cumhur, 2021. PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia. European Journal of Pharmacology
8-) Göker Bağca Bakiye, Özateş Ay Neslihan Pınar, Aşık Aycan, Caglar Hasan Onur, Gündüz Cumhur, Biray Avcı Çığır, 2020. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells. Biochemical and Biophysical Research Communications
9-) Aşık Aycan, Özateş Ay Neslihan Pınar, Göker Bağca Bakiye, Çağlar Hasan Onur, Gündüz Cumhur, Biray Avcı Çığır, 2020. Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells. Anti-Cancer Agents in Medicinal Chemistry
10-) Özgönül Ali Mert, Aşık Aycan, Durmaz Burak, Aslaminabad Ramin, Gündüz Cumhur, Yıldırım Sözmen Eser, 2020. Antiproliferative effect of rosehip tea phenolics in prostate cancer cell lines. Turkish Journal of Biochemistry
11-) Sogutlu Fatma, Kayabasi Cagla, Ozmen Yelken Besra, Aşık Aycan, Gasimli Roya, Dogan Fatma, Yılmaz Süslüer Sunde, Biray Avcı Çığır, Gündüz Cumhur, 2019. The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer. Journal of Cellular Biochemistry
12-) Yılmaz Süslüer Sunde, Kayabaşı Çağla, Özmen Yelken Besra, Aşık Aycan, Çelik Didem, Balcı Tuğçe, Serin Senger Suheyla, Biray Avcı Çığır, Köse Şükran, Gündüz Cumhur, 2018. Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients. Bosnian Journal of Basic Medical Sciences
13-) Aşık Aycan, Kayabaşı Çağla, Özmen Yelken Besra, Yılmaz Süslüer Sunde, Dogan Şiğva Zeynep Özlem, Balcı Tuğçe, Saydam Güray, Biray Avcı Çığır, Gündüz Cumhur, 2018. Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line. Gene
14-) Kayabasi Cagla, Balcı Tuğçe, Yelken Besra Ozmen, Aşık Aycan, Yılmaz Süslüer Sunde, Biray Avcı Çığır, Saydam Güray, Gündüz Cumhur, 2017. Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia. GENE
15-) Eminoğlu Ayşenur, Vullo Daniela, Aşık Aycan, Çolak Dilşat Nigar, Çanakçı Sabriye, Beldüz Ali Osman, Supuran Claudiu T, 2016. Sulfonamide inhibition studies of the ß-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13. Bioorganic Medicinal Chemistry Letters
16-) Eminoğlu Ayşenur, Vullo Daniela, Aşık Aycan, Çolak Dilşat Nigar, Supuran Claudiu T, Çanakçı Sabriye, Beldüz Ali Osman, 2015. Cloning, expression and biochemical characterization of a ß-carbonic anhydrase from the soil bacterium Enterobacter sp. B13. Journal of Enzyme Inhibition and Medicinal Chemistry
(E-1) SCIE veya SSCI tarafından taranan ve %10’luk dilimde yer alan dergide yapılan atıf
1-) Conversion of specific lncRNAs to biomarkers in exhaled breath condensate samples of patients with advanced stage non-small-cell lung cancer - Atıf Yılı: 2023 Atıf Sayısı: 2
2-) Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis - Atıf Yılı: 2023 Atıf Sayısı: 1
3-) Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells - Atıf Yılı: 2023 Atıf Sayısı: 4
4-) Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line - Atıf Yılı: 2023 Atıf Sayısı: 4
5-) Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients - Atıf Yılı: 2023 Atıf Sayısı: 2
6-) Sulfonamide inhibition studies of the ß-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13 - Atıf Yılı: 2023 Atıf Sayısı: 1
7-) Cloning, expression and biochemical characterization of a ß-carbonic anhydrase from the soil bacterium Enterobacter sp. B13 - Atıf Yılı: 2023 Atıf Sayısı: 1
8-) The Evaluation of Effect of Aurora Kinase Inhibitor CCT137690 in Melanoma and Melanoma Cancer Stem Cell - Atıf Yılı: 2023 Atıf Sayısı: 1
9-) Antiproliferative effect of rosehip tea phenolics in prostate cancer cell lines - Atıf Yılı: 2023 Atıf Sayısı: 1
10-) Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia - Atıf Yılı: 2023 Atıf Sayısı: 1
11-) PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia - Atıf Yılı: 2023 Atıf Sayısı: 3